|
1
|
Bieber T: Atopic dermatitis. Ann Dermatol.
22:125–137. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Boguniewicz M and Leung DY: Atopic
dermatitis: A disease of altered skin barrier and immune
dysregulation. Immunol Rev. 242:233–246. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Dai X, Sayama K, Tohyama M, Shirakata Y,
Hanakawa Y, Tokumaru S, Yang L, Hirakawa S and Hashimoto K: Mite
allergen is a danger signal for the skin via activation of
inflammasome in keratinocytes. J Allergy Clin Immunol.
127:806–14.e1. 42011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Choi JK, Oh HM, Lee S, Park JW, Khang D,
Lee SW, Lee WS, Rho MC and Kim SH: Oleanolic acid acetate inhibits
atopic dermatitis and allergic contact dermatitis in a murine
model. Toxicol Appl Pharmacol. 269:72–80. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kwon HK, Lee CG, So JS, Chae CS, Hwang JS,
Sahoo A, Nam JH, Rhee JH, Hwang KC and Im SH: Generation of
regulatory dendritic cells and CD4+Foxp3+ T
cells by probiotics administration suppresses immune disorders.
Proc Natl Acad Sci USA. 107:2159–2164. 2010. View Article : Google Scholar
|
|
6
|
Kim JY, Jeong MS, Park MK, Lee MK and Seo
SJ: Time-dependent progression from the acute to chronic phases in
atopic dermatitis induced by epicutaneous allergen stimulation in
NC/Nga mice. Exp Dermatol. 23:53–57. 2014. View Article : Google Scholar
|
|
7
|
Oyoshi MK, He R, Kumar L, Yoon J and Geha
RS: Cellular and molecular mechanisms in atopic dermatitis. Adv
Immunol. 102:135–226. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Matsushima H, Hayashi S and Shimada S:
Skin scratching switches immune responses from Th2 to Th1 type in
epicutaneously immunized mice. J Dermatol Sci. 32:223–230. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Novak N: New insights into the mechanism
and management of allergic diseases: Atopic dermatitis. Allergy.
64:265–275. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yoon SY, Kang HB, Ko YE, Shin SH, Kim YJ,
Sohn KY, Han YH, Chong S and Kim JW:
1-palmitoyl-2-linoleoyl-3-acetyl-rac-glycerol (EC-18) Modulates Th2
Immunity through Attenuation of IL-4 Expression. Immune Netw.
15:100–109. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kaiko GE and Foster PS: New insights into
the generation of Th2 immunity and potential therapeutic targets
for the treatment of asthma. Curr Opin Allergy Clin Immunol.
11:39–45. 2011. View Article : Google Scholar
|
|
12
|
Girolomoni G and Pastore S: Epithelial
cells and atopic diseases. Curr Allergy Asthma Rep. 1:481–482.
2001. View Article : Google Scholar
|
|
13
|
Trautmann A, Akdis M, Schmid-Grendelmeier
P, Disch R, Bröcker EB, Blaser K and Akdis CA: Targeting
keratinocyte apoptosis in the treatment of atopic dermatitis and
allergic contact dermatitis. J Allergy Clin Immunol. 108:839–846.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wollenberg A and Ehmann LM: Long term
treatment concepts and proactive therapy for atopic eczema. Ann
Dermatol. 24:253–260. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hsu CJ and Wang LF: Emerging treatment of
atopic dermatitis. Clin Rev Allergy Immunol. 33:199–203. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Choi JH, Jin SW, Park BH, Kim HG, Khanal
T, Han HJ, Hwang YP, Choi JM, Chung YC, Hwang SK, et al: Cultivated
ginseng inhibits 2,4-dinitrochlorobenzene-induced atopic
dermatitis-like skin lesions in NC/Nga mice and TNF-α/IFN-γ-induced
TARC activation in HaCaT cells. Food Chem Toxicol. 56:195–203.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kim HH, Kim DS, Kim SW, Lim SH, Kim DK,
Shin TY and Kim SH: Inhibitory effects of Diospyros kaki in a model
of allergic inflammation: Role of cAMP, calcium and nuclear
factor-κB. Int J Mol Med. 32:945–951. 2013.PubMed/NCBI
|
|
18
|
Jung HG, Kim HH, Paul S, Jang JY, Cho YH,
Kim HJ, Yu JM, Lee ES, An BJ, Kang SC, et al:
Quercetin-3-O-β-d-glucopyranosyl-(1→6)-β-d-glucopyranoside
suppresses melanin synthesis by augmenting p38 MAPK and CREB
signaling pathways and subsequent cAMP downregulation in murine
melanoma cells. Saudi J Biol Sci. 22:706–713. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Bei W, Zang L, Guo J, Peng W, Xu A, Good
DA, Hu Y, Wu W, Hu D, Zhu X, et al: Neuroprotective effects of a
standardized flavonoid extract from Diospyros kaki leaves. J
Ethnopharmacol. 126:134–142. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sa YS, Kim SJ and Choi HS: The
anticoagulant fraction from the leaves of Diospyros kaki L. has an
antithrombotic activity. Arch Pharm Res. 28:667–674. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Singh S and Joshi h: Diospyros kaki
(Ebenaceae): A Review. Asian J Res Pharm Sci. 1:55–58. 2011.
|
|
22
|
Tsang MS, Jiao D, Chan BC, Hon KL, Leung
PC, Lau CB, Wong EC, Cheng L, Chan CK, Lam CW, et al:
Anti-inflammatory activities of pentaherbs formula, berberine,
gallic acid and chlorogenic acid in atopic dermatitis-like skin
inflammation. Molecules. 21:5192016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Karuppagounder V, Arumugam S,
Thandavarayan RA, Sreedhar R, Giridharan VV and Watanabe K:
Molecular targets of quercetin with anti-inflammatory properties in
atopic dermatitis. Drug Discov Today. 21:632–639. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Han NR, Kim HM and Jeong HJ: The
β-sitosterol attenuates atopic dermatitis-like skin lesions through
downregulation of TSLP. Exp Biol Med (Maywood). 239:454–464. 2014.
View Article : Google Scholar
|
|
25
|
Bae Y, Lee S and Kim SH: Chrysin
suppresses mast cell-mediated allergic inflammation: Involvement of
calcium, caspase-1 and nuclear factor-κB. Toxicol Appl Pharmacol.
254:56–64. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lee S, Yun HS and Kim SH: The comparative
effects of mesoporous silica nanoparticles and colloidal silica on
inflammation and apoptosis. Biomaterials. 32:9434–9443. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Leung DYM, Boguniewicz M, Howell MD,
Nomura I and Hamid QA: New insights into atopic dermatitis. J Clin
Invest. 113:651–657. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
28
|
Guttman-Yassky E, Nograles KE and Krueger
JG: Contrasting pathogenesis of atopic dermatitis and psoriasis -
part I: Clinical and pathologic concepts. J Allergy Clin Immunol.
127:1110–1118. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kim SY, Sohn EJ, Kim DW, Jeong HJ, Kim MJ,
Kang HW, Shin MJ, Ahn EH, Kwon SW, Kim YN, et al: Transduced
PEP-1-FK506BP ameliorates atopic dermatitis in NC/Nga mice. J
Invest Dermatol. 131:1477–1485. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kwon DJ, Bae YS, Ju SM, Goh AR, Youn GS,
Choi SY and Park J: Casuarinin suppresses TARC/CCL17 and MDC/CCL22
production via blockade of NF-κB and STAT1 activation in HaCaT
cells. Biochem Biophys Res Commun. 417:1254–1259. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Xie C, Xie Z, Xu X and Yang D: Persimmon
(Diospyros kaki L.) leaves: A review on traditional uses,
phytochemistry and pharmacological properties. J Ethnopharmacol.
163:229–240. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Matsumoto M, Kotani M, Fujita A, Higa S,
Kishimoto T, Suemura M and Tanaka T: Oral administration of
persimmon leaf extract ameliorates skin symptoms and transepidermal
water loss in atopic dermatitis model mice, NC/Nga. Br J Dermatol.
146:221–227. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Oka T, Rios EJ, Tsai M, Kalesnikoff J and
Galli SJ: Rapid desensitization induces internalization of
antigen-specific IgE on mouse mast cells. J Allergy Clin Immunol.
132:922–32. e1–16. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Kawakami T, Ando T, Kimura M, Wilson BS
and Kawakami Y: Mast cells in atopic dermatitis. Curr Opin Immunol.
21:666–678. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Greaves MW: Antihistamines in dermatology.
Skin Pharmacol Physiol. 18:220–229. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Akdis CA, Akdis M, Bieber T,
Bindslev-Jensen C, Boguniewicz M, Eigenmann P, Hamid Q, Kapp A,
Leung DY, Lipozencic J, et al: Diagnosis and treatment of atopic
dermatitis in children and adults: European Academy of Allergology
and Clinical Immunology/American Academy of Allergy, Asthma and
Immunology/PRACTALL Consensus Report. J Allergy Clin Immunol.
118:152–169. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Shimada Y, Takehara K and Sato S: Both Th2
and Th1 chemokines (TARC/CCL17, MDC/CCL22, and Mig/CXCL9) are
elevated in sera from patients with atopic dermatitis. J Dermatol
Sci. 34:201–208. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Jahnz-Rozyk K, Targowski T, Paluchowska E,
Owczarek W and Kucharczyk A: Serum thymus and activation-regulated
chemokine, macrophage-derived chemokine and eotaxin as markers of
severity of atopic dermatitis. Allergy. 60:685–688. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Schmitt J, von Kobyletzki L, Svensson A
and Apfelbacher C: Efficacy and tolerability of proactive treatment
with topical corticosteroids and calcineurin inhibitors for atopic
eczema: Systematic review and meta-analysis of randomized
controlled trials. Br J Dermatol. 164:415–428. 2011. View Article : Google Scholar
|
